Publix heiress known for philanthropy dies in Florida at 65
The billionaire daughter of the Publix Super Markets founder has died after having early-onset Alzheimer's Disease, the company announced Wednesday. Carol Jenkins Barnett was 65. Barnett died Tuesday night at her home in Lakeland, Florida, Publix said in a news release.news.yahoo.com
2 Asian American women stabbed in San Francisco attack
Police arrested a man who they say is suspected of stabbing two Asian American women without warning Tuesday afternoon in San Francisco's Mid-Market area. A 54-year-old San Francisco man was arrested on suspicion of committing the attack several hours later, police told the station. Asian Americans have been the target of several unprovoked attacks in the San Francisco Bay Area in recent months.news.yahoo.com
Why Alzheimer’s disease is expected to remain a growing health issue in the U.S.
Alzheimer’s disease is not only a big problem now, but experts with the Alzheimer’s Association say that without a cure, it will continue to stay this way for the long term. Alzheimer’s disease -- a degenerative brain disease that is a form of dementia and affects memory, thinking and behavior -- affects more than 5 million people, according to the Alzheimer’s Association. Alzheimer’s disease and other forms of dementia kill more seniors than breast and prostate cancer combined. Between 2000 and 2018, deaths from Alzheimer’s disease have increased 146%. For more information on Alzheimer’s disease, its signs and symptoms, click or tap here.
Biogen's stock rises 4% after company releases new data on late-stage Alzheimer's drug
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. Biogen shares rose Thursday after the biotech firm offered more data on its late-stage Alzheimer's drug, aducanumab. The data, presented at the Clinical Trials on Alzheimer's Disease conference, offered almost no new results from what the company previously released in October. Dr. Eric Siemers, an Alzheimer's expert who previously led Alzheimer's research at Eli Lilly, also noted the company offered a more detailed look but "almost the same as they showed" previously. Prior to the announcement, Biogen shares were halted at $286.83.cnbc.com
Biogen's stock could fall 10% on new Alzheimer's drug data this week, top analyst says
Biogen's stock could fall as much as 10% once it releases new data this week on its Alzheimer's drug, aducanumab, Baird biotech analyst Brian Skorney told CNBC on Monday. Shares of Biogen were down more than 2% in intraday trading Monday after Skorney wrote in a note to investors that he is skeptical Biogen's Alzheimer's drug will be approved by federal regulators. In March, Biogen pulled the plug on its Alzheimer's drug and sent its stock tanking after an analysis from an independent audit revealed the experimental medicine was unlikely to work. Biogen's drug targets a compound in the brain known as beta-amyloid, which is thought to play a role in the devastating disease by eroding synapses between nerve cells. Biogen is expected to release new data for its drug at the Clinical Trials on Alzheimer's Disease annual congress on Thursday.cnbc.com
By the numbers: Alzheimer's disease in Michigan
Alzheimer's disease is a heart breaking, life changing ailment that impacts families around Michigan every year. Over five million Americans are living with Alzheimer's, and as many as 16 million will have it by 2050, according to the Alzheimer's Association. The 2018 Walk to End Alzheimer's in Detroit is coming up on Saturday, August 25. You can register, donate or volunteer here. Alzheimer's disease in Michigan